Novartis IBS therapy

FDA and Novartis have agreed to the trade name Zelnorm for the irritable bowel syndrome agent tegaserod (formerly Zelmac). FDA requested a new name based on the potential for confusion with other brands. The user fee review deadline for Zelnorm is in June